Standard Biotools (LAB) Gross Margin Growth (1y) (2011 - 2026)
Standard Biotools (LAB) Gross Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 186.78 Bn | 179.48 Bn | 6.27 Bn | -67.00 |
| 2 | Stryker | 131.95 Bn | 129.07 Bn | 3.81 Bn | -54.00 |
| 3 | Medtronic | 111.27 Bn | 102.05 Bn | 6.41 Bn | 60.00 |
| 4 | Boston Scientific | 68.58 Bn | 67.13 Bn | 3.61 Bn | 62.00 |
| 5 | Edwards Lifesciences | 48.31 Bn | 44.63 Bn | 1.29 Bn | -65.00 |
| 6 | GE HealthCare Technologies | 29.23 Bn | 26.94 Bn | 1.98 Bn | -359.00 |
| 7 | Dexcom | 28.90 Bn | 27.78 Bn | 750.30 Mn | 610.00 |
| 8 | Smith & Nephew | 28.19 Bn | 27.62 Bn | - | - |
| 9 | Koninklijke Philips | 24.33 Bn | 21.29 Bn | 2.01 Bn | 9.00 |
| 10 | Standard Biotools | 305.20 Mn | -149.97 Mn | 11.31 Mn | -116.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -116.00 |
| Dec 31, 2025 | 200.00 |
| Sep 30, 2025 | -640.00 |
| Jun 30, 2025 | 271.00 |
| Mar 31, 2025 | 152.00 |
| Dec 31, 2024 | -155.00 |
| Sep 30, 2024 | 1,093.00 |
| Jun 30, 2024 | -304.00 |
| Mar 31, 2024 | 422.00 |
| Dec 31, 2023 | 606.00 |
| Sep 30, 2023 | 802.00 |
| Jun 30, 2023 | 2,559.00 |
| Mar 31, 2023 | -4,383.00 |
| Sep 30, 2022 | -2,319.00 |
| Jun 30, 2022 | -7,022.00 |
| Mar 31, 2022 | 2,829.00 |
| Sep 30, 2021 | 696.00 |
| Jun 30, 2021 | 4,842.00 |
| Mar 31, 2021 | 1,736.00 |
| Dec 31, 2020 | 3,867.00 |